Supportive initiatives by the public and private sector for R&D with respect to various therapeutic areas, rising adoption of AI-based technologies among pharmaceutical companies and academia, and growing penetration of artificial intelligence (AI), are among the factors driving the market.
The global AI-based Clinical Trials Solution Provider market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for AI-based Clinical Trials Solution Provider is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for AI-based Clinical Trials Solution Provider is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for AI-based Clinical Trials Solution Provider in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of AI-based Clinical Trials Solution Provider include Unlearn.AI, Inc., Saama Technologies, Antidote Technologies, Inc., Phesi, Deep 6 AI, Innoplexus, Mendel.ai, Intelligencia and Median Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI-based Clinical Trials Solution Provider, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-based Clinical Trials Solution Provider.
Report Scope
The AI-based Clinical Trials Solution Provider market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI-based Clinical Trials Solution Provider market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-based Clinical Trials Solution Provider companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Unlearn.AI, Inc.
Saama Technologies
Antidote Technologies, Inc.
Phesi
Deep 6 AI
Innoplexus
Mendel.ai
Intelligencia
Median Technologies
Symphony AI
BioAge Labs, Inc.
AiCure, LLC
CONSILX
DEEP LENS AI
Halo Health Systems
Pharmaseal
Ardigen
Trials.Ai
Koneksa Health
Euretos
BioSymetrics
Google- Verily
GNS Healthcare
IBM Watson
Exscientia
Segment by Type
Phase-I
Phase-II
Phase-III
Segment by Application
Pharmaceutical Companies
Academia
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-based Clinical Trials Solution Provider companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global AI-based Clinical Trials Solution Provider 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Phase-I
1.2.3 Phase-II
1.2.4 Phase-III
1.3 麻豆原创 by Application
1.3.1 Global AI-based Clinical Trials Solution Provider 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Academia
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-based Clinical Trials Solution Provider 麻豆原创 Perspective (2019-2030)
2.2 AI-based Clinical Trials Solution Provider Growth Trends by Region
2.2.1 Global AI-based Clinical Trials Solution Provider 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI-based Clinical Trials Solution Provider Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 AI-based Clinical Trials Solution Provider Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 AI-based Clinical Trials Solution Provider 麻豆原创 Dynamics
2.3.1 AI-based Clinical Trials Solution Provider Industry Trends
2.3.2 AI-based Clinical Trials Solution Provider 麻豆原创 Drivers
2.3.3 AI-based Clinical Trials Solution Provider 麻豆原创 Challenges
2.3.4 AI-based Clinical Trials Solution Provider 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-based Clinical Trials Solution Provider Players by Revenue
3.1.1 Global Top AI-based Clinical Trials Solution Provider Players by Revenue (2019-2024)
3.1.2 Global AI-based Clinical Trials Solution Provider Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global AI-based Clinical Trials Solution Provider 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI-based Clinical Trials Solution Provider Revenue
3.4 Global AI-based Clinical Trials Solution Provider 麻豆原创 Concentration Ratio
3.4.1 Global AI-based Clinical Trials Solution Provider 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-based Clinical Trials Solution Provider Revenue in 2023
3.5 AI-based Clinical Trials Solution Provider Key Players Head office and Area Served
3.6 Key Players AI-based Clinical Trials Solution Provider Product Solution and Service
3.7 Date of Enter into AI-based Clinical Trials Solution Provider 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-based Clinical Trials Solution Provider Breakdown Data by Type
4.1 Global AI-based Clinical Trials Solution Provider Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global AI-based Clinical Trials Solution Provider Forecasted 麻豆原创 Size by Type (2025-2030)
5 AI-based Clinical Trials Solution Provider Breakdown Data by Application
5.1 Global AI-based Clinical Trials Solution Provider Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global AI-based Clinical Trials Solution Provider Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America AI-based Clinical Trials Solution Provider 麻豆原创 Size (2019-2030)
6.2 North America AI-based Clinical Trials Solution Provider 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI-based Clinical Trials Solution Provider 麻豆原创 Size by Country (2019-2024)
6.4 North America AI-based Clinical Trials Solution Provider 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-based Clinical Trials Solution Provider 麻豆原创 Size (2019-2030)
7.2 Europe AI-based Clinical Trials Solution Provider 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI-based Clinical Trials Solution Provider 麻豆原创 Size by Country (2019-2024)
7.4 Europe AI-based Clinical Trials Solution Provider 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI-based Clinical Trials Solution Provider 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific AI-based Clinical Trials Solution Provider 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI-based Clinical Trials Solution Provider 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific AI-based Clinical Trials Solution Provider 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI-based Clinical Trials Solution Provider 麻豆原创 Size (2019-2030)
9.2 Latin America AI-based Clinical Trials Solution Provider 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI-based Clinical Trials Solution Provider 麻豆原创 Size by Country (2019-2024)
9.4 Latin America AI-based Clinical Trials Solution Provider 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-based Clinical Trials Solution Provider 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa AI-based Clinical Trials Solution Provider 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI-based Clinical Trials Solution Provider 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa AI-based Clinical Trials Solution Provider 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Unlearn.AI, Inc.
11.1.1 Unlearn.AI, Inc. Company Detail
11.1.2 Unlearn.AI, Inc. Business Overview
11.1.3 Unlearn.AI, Inc. AI-based Clinical Trials Solution Provider Introduction
11.1.4 Unlearn.AI, Inc. Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.1.5 Unlearn.AI, Inc. Recent Development
11.2 Saama Technologies
11.2.1 Saama Technologies Company Detail
11.2.2 Saama Technologies Business Overview
11.2.3 Saama Technologies AI-based Clinical Trials Solution Provider Introduction
11.2.4 Saama Technologies Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.2.5 Saama Technologies Recent Development
11.3 Antidote Technologies, Inc.
11.3.1 Antidote Technologies, Inc. Company Detail
11.3.2 Antidote Technologies, Inc. Business Overview
11.3.3 Antidote Technologies, Inc. AI-based Clinical Trials Solution Provider Introduction
11.3.4 Antidote Technologies, Inc. Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.3.5 Antidote Technologies, Inc. Recent Development
11.4 Phesi
11.4.1 Phesi Company Detail
11.4.2 Phesi Business Overview
11.4.3 Phesi AI-based Clinical Trials Solution Provider Introduction
11.4.4 Phesi Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.4.5 Phesi Recent Development
11.5 Deep 6 AI
11.5.1 Deep 6 AI Company Detail
11.5.2 Deep 6 AI Business Overview
11.5.3 Deep 6 AI AI-based Clinical Trials Solution Provider Introduction
11.5.4 Deep 6 AI Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.5.5 Deep 6 AI Recent Development
11.6 Innoplexus
11.6.1 Innoplexus Company Detail
11.6.2 Innoplexus Business Overview
11.6.3 Innoplexus AI-based Clinical Trials Solution Provider Introduction
11.6.4 Innoplexus Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.6.5 Innoplexus Recent Development
11.7 Mendel.ai
11.7.1 Mendel.ai Company Detail
11.7.2 Mendel.ai Business Overview
11.7.3 Mendel.ai AI-based Clinical Trials Solution Provider Introduction
11.7.4 Mendel.ai Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.7.5 Mendel.ai Recent Development
11.8 Intelligencia
11.8.1 Intelligencia Company Detail
11.8.2 Intelligencia Business Overview
11.8.3 Intelligencia AI-based Clinical Trials Solution Provider Introduction
11.8.4 Intelligencia Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.8.5 Intelligencia Recent Development
11.9 Median Technologies
11.9.1 Median Technologies Company Detail
11.9.2 Median Technologies Business Overview
11.9.3 Median Technologies AI-based Clinical Trials Solution Provider Introduction
11.9.4 Median Technologies Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.9.5 Median Technologies Recent Development
11.10 Symphony AI
11.10.1 Symphony AI Company Detail
11.10.2 Symphony AI Business Overview
11.10.3 Symphony AI AI-based Clinical Trials Solution Provider Introduction
11.10.4 Symphony AI Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.10.5 Symphony AI Recent Development
11.11 BioAge Labs, Inc.
11.11.1 BioAge Labs, Inc. Company Detail
11.11.2 BioAge Labs, Inc. Business Overview
11.11.3 BioAge Labs, Inc. AI-based Clinical Trials Solution Provider Introduction
11.11.4 BioAge Labs, Inc. Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.11.5 BioAge Labs, Inc. Recent Development
11.12 AiCure, LLC
11.12.1 AiCure, LLC Company Detail
11.12.2 AiCure, LLC Business Overview
11.12.3 AiCure, LLC AI-based Clinical Trials Solution Provider Introduction
11.12.4 AiCure, LLC Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.12.5 AiCure, LLC Recent Development
11.13 CONSILX
11.13.1 CONSILX Company Detail
11.13.2 CONSILX Business Overview
11.13.3 CONSILX AI-based Clinical Trials Solution Provider Introduction
11.13.4 CONSILX Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.13.5 CONSILX Recent Development
11.14 DEEP LENS AI
11.14.1 DEEP LENS AI Company Detail
11.14.2 DEEP LENS AI Business Overview
11.14.3 DEEP LENS AI AI-based Clinical Trials Solution Provider Introduction
11.14.4 DEEP LENS AI Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.14.5 DEEP LENS AI Recent Development
11.15 Halo Health Systems
11.15.1 Halo Health Systems Company Detail
11.15.2 Halo Health Systems Business Overview
11.15.3 Halo Health Systems AI-based Clinical Trials Solution Provider Introduction
11.15.4 Halo Health Systems Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.15.5 Halo Health Systems Recent Development
11.16 Pharmaseal
11.16.1 Pharmaseal Company Detail
11.16.2 Pharmaseal Business Overview
11.16.3 Pharmaseal AI-based Clinical Trials Solution Provider Introduction
11.16.4 Pharmaseal Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.16.5 Pharmaseal Recent Development
11.17 Ardigen
11.17.1 Ardigen Company Detail
11.17.2 Ardigen Business Overview
11.17.3 Ardigen AI-based Clinical Trials Solution Provider Introduction
11.17.4 Ardigen Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.17.5 Ardigen Recent Development
11.18 Trials.Ai
11.18.1 Trials.Ai Company Detail
11.18.2 Trials.Ai Business Overview
11.18.3 Trials.Ai AI-based Clinical Trials Solution Provider Introduction
11.18.4 Trials.Ai Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.18.5 Trials.Ai Recent Development
11.19 Koneksa Health
11.19.1 Koneksa Health Company Detail
11.19.2 Koneksa Health Business Overview
11.19.3 Koneksa Health AI-based Clinical Trials Solution Provider Introduction
11.19.4 Koneksa Health Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.19.5 Koneksa Health Recent Development
11.20 Euretos
11.20.1 Euretos Company Detail
11.20.2 Euretos Business Overview
11.20.3 Euretos AI-based Clinical Trials Solution Provider Introduction
11.20.4 Euretos Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.20.5 Euretos Recent Development
11.21 BioSymetrics
11.21.1 BioSymetrics Company Detail
11.21.2 BioSymetrics Business Overview
11.21.3 BioSymetrics AI-based Clinical Trials Solution Provider Introduction
11.21.4 BioSymetrics Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.21.5 BioSymetrics Recent Development
11.22 Google- Verily
11.22.1 Google- Verily Company Detail
11.22.2 Google- Verily Business Overview
11.22.3 Google- Verily AI-based Clinical Trials Solution Provider Introduction
11.22.4 Google- Verily Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.22.5 Google- Verily Recent Development
11.23 GNS Healthcare
11.23.1 GNS Healthcare Company Detail
11.23.2 GNS Healthcare Business Overview
11.23.3 GNS Healthcare AI-based Clinical Trials Solution Provider Introduction
11.23.4 GNS Healthcare Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.23.5 GNS Healthcare Recent Development
11.24 IBM Watson
11.24.1 IBM Watson Company Detail
11.24.2 IBM Watson Business Overview
11.24.3 IBM Watson AI-based Clinical Trials Solution Provider Introduction
11.24.4 IBM Watson Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.24.5 IBM Watson Recent Development
11.25 Exscientia
11.25.1 Exscientia Company Detail
11.25.2 Exscientia Business Overview
11.25.3 Exscientia AI-based Clinical Trials Solution Provider Introduction
11.25.4 Exscientia Revenue in AI-based Clinical Trials Solution Provider Business (2019-2024)
11.25.5 Exscientia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Unlearn.AI, Inc.
Saama Technologies
Antidote Technologies, Inc.
Phesi
Deep 6 AI
Innoplexus
Mendel.ai
Intelligencia
Median Technologies
Symphony AI
BioAge Labs, Inc.
AiCure, LLC
CONSILX
DEEP LENS AI
Halo Health Systems
Pharmaseal
Ardigen
Trials.Ai
Koneksa Health
Euretos
BioSymetrics
Google- Verily
GNS Healthcare
IBM Watson
Exscientia
听
听
*If Applicable.
